George Scangos, president and CEO of Vir Biotechnology, describes how the biotech industry has changed over the past several decades. Advances in both the speed of genetic research and the capabilities of data science, as well as some prominent successes, he finds, have accelerated biotech investments and innovation.
Related
Kristen Fortney,
BioAge Labs
Derisking Biotech [Entire Talk]
Biotech offers huge rewards for founders who approach risk strategically.
Kristen Fortney,
BioAge Labs
Derisking Biotech [Entire Talk]
Biotech offers huge rewards for founders who approach risk strategically.
Alfred Lin,
Sequoia Capital
Developing a Founder’s Mindset [Entire Talk]
Strategic founders pursue calculated risks and are willing to evolve.
Alfred Lin,
Sequoia Capital
Developing a Founder’s Mindset [Entire Talk]
Strategic founders pursue calculated risks and are willing to evolve.
Jorge Rios,
Bridgefy
Seizing Global Opportunities [Entire Talk]
Discover new opportunities by thinking beyond borders.
Jorge Rios,
Bridgefy
Seizing Global Opportunities [Entire Talk]
Discover new opportunities by thinking beyond borders.
